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of the RILab and, lastly, we will outline the project’s timeline with appropriate milestones, costs,
and funding.
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Our company, livEn, is a biomedical engineering company bridging the ophthalmology field and
engineering field together to design state of the art laser eye therapy systems.
The Problem
● Lack of useful training options for laser eye therapies.[1]
● Shortage of ophthalmologists.[2]
● Manual processes require cognitive safety checks by the ophthalmologist which may
leave a margin for user error.
● Growing number of patients necessitating laser eye therapies.[3]
The Solution
● The Retina Imager and Laser Beamer (RILab) is a semi-automated all-in-one system to
safely, easily, and efficiently perform laser eye therapies.
The Market
● Ophthalmologists
● Medical Residency Students
The Benefits
● An efficient device that can speed
up laser eye therapies and decrease
hands-on tasks for
ophthalmologists.
● A useful training option for medical
residency students. Expected growth of vision impairment and blindness [3]
● Software that checks and confirms the
appropriate safety checks and protocols.
The Development to Success
● Iterative Design: Identify & modify, design, construct, and evaluate
● Partnership with Dr. Zaid Mammo at the Vancouver General Hospital.
● Proof-of-Concept completed by April 23rd.
● Beta-Phase completed by the end of August.
The Funding
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1 livEn
We were formed by a group of two biomedical engineers and four computer engineers who are
looking to make an impact on the world and improve the well-being of humans. Our name is
derived off the root words “live” and “engineering”, combining to form livEn. We are a group of
individuals who are interested in bridging together our engineering sector with the medical
sector for healthy lives. We are currently focused on the ophthalmology field which contributes
to our company name and logo. The cross-shaped logo seen in Figure 1.1 represents the
medical sector whereas the array of circles represents the dotted laser pattern seen through
many laser eye surgeries. The capital E in “En” represents our roots as engineering students
while the lowercase l in “liv” serves as an aesthetic to distinguish our company name.




Image processing, machine learning, control algorithm
edurech@sfu.ca
Eduard is a 4th-year Biomedical Engineering student with two and a half years of academic
research experience in image/data processing and machine learning. He is interested in
medical applications of machine learning and data science. Eduard will be developing the image
processing and machine learning pipelines for detection and segmentation of diseased and






Dasha is a 5th-year Biomedical Engineering student with an interest in medical imaging. She has
done volunteering and worked at Biomedical Optics Research Group with a focus in optical
imaging; in addition, her previous experience includes quality assurance of medical imaging
software at Change Healthcare. Dasha will be implementing the RILab’s graphical user interface





Documentation, Administration, UI/UX Evaluation
bvle@sfu.ca
Vincent is a 5th-year Computer Engineering student with a passion for technology and business
in the world. His experience in Information Technology at the BC Cancer Research Centre,
Simon Fraser University, and the University of British Columbia gives him the necessary





Hardware Integration, Electronics & CAD design
pchaudha@sfu.ca
Puru is a 5th-year Computer Engineering student who has experience as a firmware engineer at
Netint Technologies and as a software developer for SFU FAS. He is interested in machine
learning and cryptography. Puru will be responsible for hardware and software integration along






Jiung is a 5th-year Computer Engineering student with an interest in VLSI design. He has
worked at Gatekeeper Systems as a QA analyst in the company's software, IP camera, and
DVR; in addition, he has project experience creating a full-stack web application. Jiung will be in




Hardware Integration, Firmware Development
ksmolko@sfu.ca
Kyle is a 4th-year Computer Engineering student with an interest in embedded and real-time
systems. His previous work experience includes co-ops working as a Firmware Developer for
Blackberry Ltd., and a Systems Engineer for Intel of Canada Ltd. Kyle will be responsible for




Laser eye therapy is a popular treatment option to correct refractive eye errors and other
abnormal developments that can lead to difficulties with sight and, in extreme cases,
blindness.[4] These therapies include, but are not limited to, Pan Retinal Photocoagulation
(PRP) and PhotoDynamic Therapy (PDT). PRP is most known for reducing the risk of vision
loss by 50% to those affected with proliferative diabetic retinopathy (PDR).[5] PDT is an older
treatment dating back to the 2000s where doctors would use a laser to activate an applied
photosensitizing agent which would collect in abnormal blood vessels in the eye.[6] Figure 2.1.1
shows an example of PRP therapy after a session of laser therapy for correction.
Figure 2.1.1: Fundus image with PRP therapy (white dots created by laser burns) [7]
These therapies are currently done manually by ophthalmologists and we, along with Professor
Dr. Marinko Sarunic and Dr. Zaid Mammo, have identified that a semi-automated system would
be needed and advantageous. The current procedure involves ophthalmologists using either slit
lamps, as seen in Figure 2.1.2, or headlamps along with a laser attached coaxially,[7] The
current procedure protocols are lengthy and require each exposure to be manually positioned
and timed, with tens of such exposures being completed per procedure. The field is also
experiencing a shortage of these specialists as per [2] and our goal is to streamline and
ameliorate their workload to cover for this shortage.
Figure 2.1.2: Current manual and fully mechanical slit lamp laser eye therapy procedure [8]
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2.2 Document Scope
This document begins by covering the project scope of the RILab in Section 2. Section 3 will
describe the target market of the RILab and its competition. Sections 4 and 5 will highlight the
risks and benefits that our system provides to our users. Following, this proposal will detail the
major processes and milestones throughout the next couple of months straight to the end of our
capstone term in Section 6. Lastly, we will discuss the costs and funding needed and provided
for the project in Section 7.
2.3 Scope
Introducing RILab
This project and device will make laser eye therapy procedures easier to perform as time will be
freed for ophthalmologists to focus on more hands-on procedures where they are most needed.
The system proposed in this document will also further enable more users, specifically medical
residency students.[1]
This product includes hardware components that will support the clinician with a guaranteed
increase of safety and efficiency as compared to current systems. We are integrating a fundus
camera, a high-powered laser, and an optical scanning mirror controlled by our software. The
control system does not consider elements such as a mounted contact lens to keep the patient’s
eyes open, and head/chin rests to keep the motion of their head still. Figure 2.3.1 features the
system as a whole.
Figure 2.3.1: High-Level System Block Diagram
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Automating the Procedure
The RILab is also an algorithmic design project used to determine where it is safe and not safe
to fire a laser onto a human retina. We are developing novel processing techniques to detect
diseased and avoidant tissue and auto-populate the therapy patterns while tracking the eye for
movement. Imaging is done via the fundus retinal camera while processing is done on a
standalone board. The auto-segmented regions may be further refined and confirmed by a
clinician to ensure safety. The appropriate regions in the patient’s retina can then be targeted by
the laser using coordinates derived from our algorithm. These coordinates guide the laser beam
via the optical scanning mirror. With the highest priority on safety, the algorithm will also decide
when it is safe to fire the laser and allow the clinician to monitor and override the procedure at
any time. During the procedure, the laser titrates its power from low to high depending on the
degree of burn needed. Figure 2.3.2 is a short block diagram that summarizes the process.
Figure 2.3.2: Block Diagram of the RILab’s Procedure
Inside RILab
Our software is controlled with a microcomputer while the rest of the equipment is set up in a
coaxial position to an eye as seen in Figure 2.3.3. The system is stationed on a stable optical
breadboard to ensure safety.
Figure 2.3.3: The inner system of the RILab
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3 Market Analysis
3.1 Target Canadian Market
5.5 million Canadians live with vision threatening eye conditions and this number is predicted to
only grow higher following the trend of an aging Canadian population as per the BC Medical
Journal.[9] This large number is indicative of the growth and need of this market. This growing
trend goes along with the trend of an aging Canadian ophthalmologist population as per Figure
3.1.1.[10]
Figure 3.1.1: Ophthalmologists age trend [10]
This denotes a growing market where the number of ophthalmologists just does not match the
need as can be seen in Figure 3.1.2 with data obtained by the Canadian Medical
Association.[10]
Figure 3.1.2: Total number & number/100000 population by province, 2019 [10]
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The number of ophthalmologists is far too few, with more than a 20% deficit in required
Opthamologists for 2020 in the United States as shown in Figure 3.1.3.[11] Canada is seeing
the same shortage, with a significant 45% of ophthalmologists feeling that they are overworked
as shown in Figure 3.1.4.[10] This encroaching Achilles’ heel in our health system motivates our
mission to ameliorate the current procedures of an ophthalmologist’s workload and also opens a
large market of opthamologists to systems which can streamline and speed up their procedures.
Figure 3.1.3: Expected number of ophthalmologist vs. the required ophthalmologists needed in
the United States by year [11]
Figure 3.1.4: Ophthalmologist satisfaction with their work hours and workload [10]
Our target market are these ophthalmologists and their setting of occupation. Data from The
Canadian Medical Association [10] shows that our primary target will be private offices and
clinics, as per Figure 3.1.5. This is epitomized by our partnership with Dr. Zaid Mammo as his
practice is based on his own office and clinic at the Vancouver General Hospital.[1]
7
Figure 3.1.5: Distribution of the target market setting [10]
3.2 Market Forecasts
The ophthalmic laser market will continue to grow in the coming years.[12] In 2016, the market
was sitting at 970.2 million USD. At a compound annual growth rate of 5.1%, a project increase
of up to 1,245.4 million USD is expected to be reached by this year, 2021. This market share is
mostly accounted for by North America with Asia-Pacific rising up in the next few years in terms
of compound annual growth rate. This rise in growth can be attributed to a high prevalence of
chronic disorders, increasing regulatory approval for the prevention of vision impairment, the
introduction of initiatives for the prevention of blindness, treatment projects for various
ophthalmic disorders, and the rising aging population.
3.3 Competition
The companies below feature our main competition. Two registered products, the
PAttern-SCAnning Laser and the NAVIgated LASer stand out as direct competitors highlighted
in SpringerLink’s published article, New Laser Technologies for Diabetic Retinopathy.[13]
Zeiss is the largest company that pioneers in scientific
optics and optoelectronics. Their work includes
research in ophthalmic devices, their production, and
consumerism in setup and function. They are an
international company headquartered in Germany with
representation in over 50 countries. 812 million EUR
are put into their research and they had a fiscal year
revenue of 6.297 million EUR in 2019/2020.[14]
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Topcon has filed a patent for semi-automated
ophthalmic photocoagulation methods and
apparatuses.[15] Their research has led them to create
the PASCAL, which would be a direct competitor to the
RILab. Topcon is a global leader in manufacturing
ophthalmic lasers with a research base in Stanford
University.[16]
OD-OS is a company that co-invented the
NAVILAS.[17] The NAVILAS is a registered trademark
for OD-OS and they continue to use it as a base to
advance in ophthalmic therapy innovations. They are a
German-American based team with solid investors as
well as a recognized ISO 13485 certified medical
device company.
Lumenis’ business is one that expands through the vast
range of medical technology. They have been known to
revolutionize currently medical treatments which is
what our company is currently aiming to do. They have
been a leader in ophthalmic laser technologies and
renowned for keeping an industry gold standard.[18]
Ellex is an international company with headquarters
across four countries that distributes globally to
hundreds of countries. Since 1985, they have made it
their mission to address the treatment needs of the
visually impaired through their OEM approved
ophthalmic laser technologies. Ellex claims to be




Laser eye therapies come with the innate risks that all ophthalmologists must highlight with their
patients. As such, our product, stakeholders, and users must be aware and review these risks
as well. These risks highlighted by [20] can include:
● Mild loss of central vision
● Reduced night vision
● Decreased ability to focus
● Mild loss of peripheral vision
Rare complications include [20]:
● Vitreous hemorrhage
● Traction retinal detachment
● Accidental laser burn of the fovea
Additional side effects as detailed by [21] include:
● Pain from laser burns
● Development or worsening of macular edema
● Loss of colour vision
● Reduction in contrast sensitivity
● Choroidal complications
These risks are very real but do have a low likelihood to be severe. Minor side-effects will have
a higher likelihood but the path of not choosing laser eye therapies will increase the risk of major
detrimental eye effects more.
Our product must also consider its own risks to increasing these effects and injuries detailed in
table 4.1.
Inaccurate segmentation of retina blood vessels
Likelihood of Risk Low
Impact of Risk High
Avoidance of Risk Thorough testing with retinal images.
Mitigation of Risk Research and gather more data to train a more accurate model. Adjust
model parameters when training.
Containment of Risk Manual checks by the clinician.
Manual segmentation by the clinician.
Imprecise retina region tracking
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Likelihood of Risk Low
Impact of Risk High
Avoidance of Risk Research upgrades on components.
Mitigation of Risk Research and gather more data to train a more accurate model. Adjust
model parameters when training.
Containment of Risk Remember to manually place a mounted contact lens to directly align
the camera with the pupil if necessary.
Imprecise and inaccurate laser control and eye damage
Likelihood of Risk Low
Impact of Risk High
Avoidance of Risk Rigorous testing of laser timing and power thresholds to minimize
likelihood of this ever occurring.
Mitigation of Risk Include confirmation pop-ups to review settings.
Test processes at a lower power before the actual procedure is done.
Containment of Risk Timed laser cut-off to minimize.
Emergency stop button.
Table 4.1: Risks Identification and Risk Management
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5 Benefits











Ease of use will be guaranteed such that an ophthalmologist can intuitively learn and move
through their laser eye therapy procedures. Usability is important and our system will feature
aesthetic designs that are pleasing to look at. This benefit further extends the capability of
residency medical students to perform the laser eye therapies.
Efficiency is guaranteed to speed up the laser eye therapy procedure for ophthalmologists. This
will provide them more time to handle other tasks, take appropriate breaks, and reduce stress.
Our streamlined process will epitomize simplicity as compared to current processes.
Safety will be a guarantee. Our system benefits from automated safety checks and manual
confirmations. Risk avoidance, mitigation, and containment are considered throughout all
phases of the system to minimize and prevent any risks and errors. The repeatability and
consistency of automation also mitigates human-error.
These three points will lead to better and more successful laser eye therapies. Risks of eye
damage will be lessened, leading to further improvement in patient satisfaction and restoring a




Our development plan is listed in GANTT charts below in Figures 6.1.1 and 6.1.2. This schedule
is made to hit all of our milestones as marked by the blue diamonds. This project projects an
eight month plan that moves from brainstorming to the proof-of-concept in 4 months, and the
details of the beta phase product in the last four months.
Figure 6.1.1: GANTT Chart of the RILab’s Development from brainstorming to the design
specification
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Figure 6.1.2: GANTT Chart of the RILab’s Development from the proof-of-concept to the beta
6.2 Milestones
6.2.1 Automation of the retinal segmentation – skeletonization, treatment &
non-treatment zones
This milestone is important to the efficiency of the RILab. This automation will speed up the time
used by a clinician and ensure safety with the non-treatment zones. Manual confirmation is still
needed to go forward with the procedure.
6.2.2 Laser/Mirror Algorithm – accuracy and precision
This milestone is important to the safety of the RILab. Our medical grade laser will be
controllable within nanometer precision in order to perform laser eye therapies in the correct
location. Laser power will also need to be titrated in order to properly perform the procedures.
6.2.3 Graphical user interface – beta-phase complete
The beta-phase graphical user interface will include all functions needed for a typical laser eye
therapy. These additional features include laser power titration, laser wavelength/colour, laser




Table 7.1.1 highlights the cost estimate of the RILab. As most parts are purchased from the US,
prices are all in US dollars.
Part Cost Per Unit (USD) Quantity Total Cost (USD)









Volk 20D Lens $359 1 $359
OBIS 488nm LS 20mW
Laser System
$5,985 1 $5,985
QS7XY-AG - Dual-Axis, Ø7
mm Beam Galvo System
$3,880 1 $3,880
NVidia Jetson Xavier NX $399 1 $399
AC254-060-B Lens $94.42 4 $377.68
AC508-075-A Lens $128.77 1 $128.77
DMLP550R Beamsplitter $254.30 1 $254.30
3D Printed Casing $200 1 $200
Table 7.1.1: Estimated costs of the RILab
Total Estimated Cost = $11,973.69 USD
At the time of writing, this comes out to ~$15,072.42 Canadian dollars.
7.2 Funding
7.2.1 BORG, Stakeholder: Dr. Marinko V. Sarunic
Our primary source of funding will be through Dr. Marinko V. Sarunic of the Biomedical Optics
Research Group. Our sponsored project and its parts will ultimately fall back to the research
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group when we have accomplished our final project appearance design and beta-phase
prototype which will be further detailed in ENSC440. Project costs, parts, and justifications are
submitted to Dr. Marinko V. Sarunic for approval.[22]
The next few sections discuss our other contingent options for funding.
7.2.2 $50 Engineering Science Parts Budget
This simple and small fund is provided to cover the costs of ordered parts. This fund can include
3D printing jobs.[23]
7.2.3 Engineering Science Student Endowment Fund (ESSEF)
The ESSEF is also known as the Engineering Science Undergraduate Student Project
Award.[24] This award is considered by a panel of judges. The funding adjudication council will
consider student project proposals through an eligible award recipient via an application form as
well as a short presentation and meeting with the entire group. Additional funding may be of
interest if the parts required by our project is of interest to the Engineering Science Parts Library
and, as such, will be owned by the Engineering Science Student Society. The RILab will be
submitted for consideration in Class C, “Projects that originate from an Engineering Science
class or a special projects laboratory.”[25]
7.2.4 Wighton Engineering Development Fund
The Wighton Engineering Development Fund is a competition-based and fixed budget fund as
organized in SFU by Dr. Andrew H. Rawicz. A written proposal similar to this proposal will be
required for submission to deem if our project will satisfy the Wighton’s requirement of




Simpler, Faster, and Safer Laser Eye Therapies
Our mission statement is to improve ophthalmic laser solutions, increasing the quality of work
and safety for clinicians and patients. Manual procedures are well developed but our company
has identified a need to improve on these procedures to ensure their safety and efficiency, as
well extend their usability to medical residency students. These in turn help in accomplishing our
mission statement.
The Canadian market for ophthalmologists and clinicians are much needed as they are
experiencing overexertion in their line of work and an aging clinician population. Training
solutions are also desired as expressed by our user interviews with our contact ophthalmologist,
Dr. Zaid Mammo. We will ensure that the RILab will be made to alleviate these issues, as
simplicity and ease of use are one of the main goals.
Our research and development will accumulate into proprietary software and algorithms used to
control our proprietary optical system. This project will ultimately show that laser eye therapies
can be successfully performed and further be developed to compete with the PASCAL and the
NAVILAS.
Our talented team of engineers have accumulated 4 years of biomedical optics and image
processing research experience, 10 years of hardware and embedded systems experience, and
20 years of software development experience. Our team also includes experts in the field such
as Professor Dr. Marinko Sarunic of the Biomedical Optics Research Group and Dr. Zaid
Mammo of Vancouver General Hospital. We are all dedicated to our mission statement and our
solid financial benefactors.
Our development plan will take into account all the highlighted risks in our document and we will
have a working beta prototype by the end of August to present. This will be the first step in
creating a working prototype of a system leading to fully-automated laser eye therapies. Such a
system enables a future where laser eye therapies are as easy as walking in for a routine eye
check and vision-robbing diseases can become a thing of the past. This remains our goal while
keeping to our core tenants of simplicity, efficiency, and safety.
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Choroid The spongy layer of blood vessels that lines the back wall of the eye.
Clinician A clinician is a doctor having direct responsibilities and contact with a
patient. In our document, this includes ophthalmologists, their assistants,
and medical resident students.
Fovea A depression in the central macula that contains no blood vessels
Fundus The bottom, the base, or the inner lining of a hollow organ. In terms of
our document, fundus will be referring to the inner lining of the eye
opposite to the lense, also known as the retina.
Macular Edema Build-up of fluid in the macula, an area in the center of the retina. This
condition causes swelling and thickening which distorts vision.
Medical Residency Postgraduate students who are training in the field of medicine.
Microcomputer A small computer ran by a single-chip microprocessor as its central
processing unit. It has memory and minimum input/output circuitry on a
single printed circuit board.
No Treatment Area A region on the image that is selected by the algorithm or selected by
the clinician where the macula and the vessels are located. No laser is
allowed to shine there.
Ophthalmologist A specialist doctor in the field, study, and treatment of disorders and
diseases in the eye.
Optical Scanning Mirror A small rectangular mirror that is able to scan a laser in two axes.
Optical Table A vibration control platform that absorbs shock and vibrations to
minimize any movements that may misalign any lasers or optical
components.
PDR Proliferative Diabetic Retinopathy is an effect as a result of diabetes.
The conditions of diabetes results in abnormal blood vessels forming in
the eye which can lead to a loss of vision.
PDT PhotoDynamic Therapy is a two-stage treatment that combines light
energy with a drug (photosensitizer) designed to destroy abnormal cells
and vessels after light activation.
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Phantom Eye A phantom eye is a term used to generalize the test subject for optics. A
phantom eye has a wide range from a piece of tissue to a piece of
paper, and a drawing of an eye to a porcine eye to a rat’s eye.
PRP Pan Retinal Photocoagulation is a laser eye therapy that can decrease
the size of abnormal blood vessels which can lead to blindness.
Retinal Camera A specialized camera that is able to photograph the retina of an eye.
Treatment Area A region on the image that is selected by the algorithm or selected by
the clinician where the laser treatment shall be applied.
Table A.1: Glossary covering the important terms in this Design Specification Document
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